DEVELOPMENT STAGE COMPANY Clause Samples
DEVELOPMENT STAGE COMPANY. Aura recognizes Ontro is a development stage company, that it has an accumulated deficit and a working capital deficit, has not generated any revenue from operations and is not expected to generate any revenue from operations for some time and perhaps for years, and that proposed development expenditures are expected to result in substantial and increasing losses over at least the next several years, and possibly much longer. Investment in Ontro involves substantial risk, and Aura should not acquire the Warrants unless it can afford the complete loss of its investment. Aura has taken full cognizance of and understands all of the risk factors related to the receipt of the Warrants.
DEVELOPMENT STAGE COMPANY. The Investor recognizes the Company is a development stage Company, that it has an accumulated deficit and a working capital deficit, has not generated any revenue from operations and is not expected to generate any revenue from operations for some time and perhaps for years, and that proposed development expenditures are expected to result in substantial and increasing losses over at least the next one or more years, and possibly much longer. Investment in the Company involves substantial risk, and the Investor can afford the complete loss of its investment. The Investor has taken full cognizance of and understands all of the risk factors related to the receipt of the Common Stock.
DEVELOPMENT STAGE COMPANY. The Company is a development stage company without any operating history. There can be no assurance that the Company will be able to implement its business plan, raise sufficient capital to fund its development or achieve a level of operating revenues or income sufficient to enable the Company to continue as a going concern. It has no commercial products and its products in development require significant further research, development, testing, and regulatory clearances and are subject to the risks of failure inherent in the development of products based on new technologies. These risks include the possibilities that the Company’s technology or any or all of its product candidates will be found to be unsafe, ineffective or toxic, especially in immunosuppressed individuals, or fail to receive necessary regulatory clearances to develop or approve the products; that the product candidates, even if found to be safe and effective, will be difficult to manufacture on a large scale or uneconomical to market; that the product candidates will be stable enough for commercialization; that proprietary rights of third parties will preclude the Company from marketing products; or that third parties will market superior or equivalent products. There can be no assurance that the Company’s research and development activities will result in any commercially viable products.
DEVELOPMENT STAGE COMPANY. The Purchaser acknowledges and understands that the Company is a development-stage company.
DEVELOPMENT STAGE COMPANY. The undersigned recognizes the Company is a development stage Company, that it has an accumulated deficit and a working capital deficit, has not generated any revenue from operations and is not expected to generate any revenue from operations for some time and perhaps for years, and that proposed development expenditures are expected to result in substantial and increasing losses over at least the next several years, and possibly much longer. Investment in the Company involves substantial risk, and the undersigned should not purchase the Common Stock unless it can afford the complete loss of its investment. The undersigned has taken full cognizance of and understands all of the risk factors related to the receipt of the Common Stock.
DEVELOPMENT STAGE COMPANY. The undersigned recognizes the Company is a development stage Company, that it has an accumulated deficit and a working capital deficit, has not generated any revenue from operations and is not expected to generate any revenue from operations for some time and perhaps for years, and that proposed development expenditures are expected to result in substantial and increasing losses over at least the next year, and possibly much longer. The undersigned recognizes investment in the Company involves substantial risk, and the undersigned should not purchase the Common Stock unless it can afford the complete loss of its investment. The undersigned has taken full cognizance of and understands all of the risk factors related to the receipt of the Common Stock.
DEVELOPMENT STAGE COMPANY. The Purchaser acknowledges and understands that the Company commenced operations in 1997.
DEVELOPMENT STAGE COMPANY. As a development stage company, the Company’s book value is dependent on its continuation as a going concern. Furthermore, the Company anticipates that it will generate an operating deficit during its initial operation. The Company intends to sub-license its portfolio products and technology to prospective customers, to commercialize the P3D technology in Europe, and to raise, or generate from operations, sufficient capital to continue as a going concern. The value of the Company’s assets would materially decrease were it to be unable to continue as a going concern.
DEVELOPMENT STAGE COMPANY. Stockholder understands fully that the Company is a development-stage company. There can be no assurance that the Company will generate any revenues, or if revenues are generated, that the Company can sustain revenues for any period of time or otherwise achieve or maintain profitability.